Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury

Blood

Volumn 125, Issue 14, 2015, Pages 2286-2296

  Chaaban, Hala ^a   Keshari, Ravi S ^b   Silasi Mansat, Robert ^b   Popescu, Narcis I ^b   Mehta D'Souza, Padmaja ^b   Lim, Yow Pin ^c   Lupu, Florea ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c ProThera Biologics Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HISTONE; HYALURONIC ACID; INHIBITOR PROTEIN; INTER ALPHA INHIBITOR PROTEIN; UNCLASSIFIED DRUG; ALPHA GLOBULIN; CYTOKINE; INTER-ALPHA-INHIBITOR; NUCLEOSOME;

ARTICLE; BLEEDING; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; TISSUE INJURY; ANIMAL; APOPTOSIS; BABOON; BLOOD CLOTTING; C57BL MOUSE; CELL CULTURE; FLOW CYTOMETRY; GLYCOCALYX; HEMORRHAGE; HL 60 CELL LINE; INFLAMMATION; MALE; METABOLISM; MOUSE; NUCLEOSOME; SEPSIS; THROMBOSIS; WESTERN BLOTTING;

ALPHA-GLOBULINS; ANIMALS; APOPTOSIS; BLOOD COAGULATION; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GLYCOCALYX; GLYCOSAMINOGLYCANS; HEMORRHAGE; HISTONES; HL-60 CELLS; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NUCLEOSOMES; PAPIO; PLATELET AGGREGATION; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84926615692     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-582759     Document Type: Article

References (63)

1. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768-2776.
2. Borissoff JI, Joosen IA, Versteylen MO, et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013;33(8): 2032-2040.
3. Chen Q, Ye L, Jin Y, et al. Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. Int J Infect Dis. 2012;16(7):e558-e564.
4. Zeerleder S, Zwart B, Wuillemin WA, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med. 2003; 31(7):1947-1951.
5. Johansson PI, Windeløv NA, Rasmussen LS, Sørensen AM, Ostrowski SR. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 2013;6(3):171-175.
6. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood. 2011;118(13):3708-3714.
7. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318-1321.
8. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011;118(7):1952-1961.
9. Brill A, Fuchs TA, Savchenko AS, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost. 2012;10(1):136-144.
10. Jacobsen F, Baraniskin A, Mertens J, et al. Activity of histone H1.2 in infected burn wounds. J Antimicrob Chemother. 2005;55(5):735-741.
11. Kleine TJ, Gladfelter A, Lewis PN, Lewis SA. Histone-induced damage of a mammalian epithelium: the conductive effect. Am J Physiol. 1995;268(5 Pt 1):C1114-C1125.
12. Currie JR, Chen-Hwang MC, Denman R, et al. Reduction of histone cytotoxicity by the Alzheimer beta-amyloid peptide precursor. Biochim Biophys Acta. 1997;1355(3):248-258.
13. Lam FW, Cruz MA, Leung HC, Parikh KS, Smith CW, Rumbaut RE. Histone induced platelet aggregation is inhibited by normal albumin. Thromb Res. 2013;132(1):69-76.
14. Wildhagen KC, García de Frutos P, Reutelingsperger CP, et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood. 2014; 123(7):1098-1101.
15. Daigo K, Nakakido M, Ohashi R, et al. Protective effect of the long pentraxin PTX3 against histonemediated endothelial cell cytotoxicity in sepsis. Sci Signal. 2014;7(343):ra88.
16. Hicks PS, Saunero-Nava L, Du Clos TW, Mold C. Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol. 1992;149(11):3689-3694.
17. Abrams ST, Zhang N, Dart C, et al. Human CRP defends against the toxicity of circulating histones. J Immunol. 2013;191(5):2495-2502.
18. Pemberton AD, Brown JK, Inglis NF. Proteomic identification of interactions between histones and plasma proteins: implications for cytoprotection. Proteomics. 2010;10(7):1484-1493.
19. Salier JP, Rouet P, Raguenez G, Daveau M. The inter-alpha-inhibitor family: from structure to regulation. Biochem J. 1996;315(Pt 1):1-9.
20. Morelle W, Capon C, Balduyck M, et al. Chondroitin sulphate covalently cross-links the three polypeptide chains of inter-alpha-trypsin inhibitor. Eur J Biochem. 1994;221(2):881-888.
21. Enghild JJ, Salvesen G, Thøgersen IB, Valnickova Z, Pizzo SV, Hefta SA. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin. J Biol Chem. 1993;268(12):8711-8716.
22. Sanggaard KW, Scavenius C, Rasmussen AJ, Wisniewski HG, Thøgersen IB, Enghild JJ. The TSG-6/HC2-mediated transfer is a dynamic process shuffling heavy chains between glycosaminoglycans. J Biol Chem. 2010;285(29): 21988-21993.
23. Potempa J, Kwon K, Chawla R, Travis J. Interalpha- trypsin inhibitor. Inhibition spectrum of native and derived forms. J Biol Chem. 1989; 264(25):15109-15114.
24. Josic D, Brown MK, Huang F, et al. Proteomic characterization of inter-alpha inhibitor proteins from human plasma. Proteomics. 2006;6(9): 2874-2885.
25. Liu Y, Jennings NL, Dart AM, Du XJ. Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice. World J Exp Med. 2012;2(2):30-36.
26. Opal SM, Lim YP, Siryaporn E, et al. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis. Crit Care Med. 2007; 35(2):387-392.
27. Hodson BA, Pepper DS, Dawes J. Novel affinity chromatographic system for the single-step purification of glycosaminoglycans from complex systems using volatile buffers. J Chromatogr A. 1991;565(1-2):416-423.
28. Abrams ST, Zhang N, Manson J, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med. 2013;187(2): 160-169.
29. Cuellar K, Chuong H, Hubbell SM, Hinsdale ME. Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II. J Biol Chem. 2007;282(8): 5195-5200.
30. Nagy N, Freudenberger T, Melchior-Becker A, et al. Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation. 2010;122(22):2313-2322.
31. Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol. 2005;26(12):637-643.
32. De Meyer SF, Suidan GL, Fuchs TA, Monestier M, Wagner DD. Extracellular chromatin is an important mediator of ischemic stroke in mice. Arterioscler Thromb Vasc Biol. 2012;32(8): 1884-1891.
33. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol. 2011;187(5):2626-2631.
34. Allam R, Scherbaum CR, Darisipudi MN, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012;23(8):1375-1388.
35. Keshari RS, Silasi-Mansat R, Zhu H, et al. Acute lung injury and fibrosis in a baboon model of Escherichia coli sepsis. Am J Respir Cell Mol Biol. 2014;50(2):439-450.
36. Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009;184(2):205-213.
37. Kutcher ME, Xu J, Vilardi RF, Ho C, Esmon CT, Cohen MJ. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg. 2012;73(6):1389-1394.
38. Bosmann M, Grailer JJ, Ruemmler R, et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J. 2013; 27(12):5010-5021.
39. Fries E, Kaczmarczyk A. Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim Pol. 2003;50(3):735-742.
40. Fries E, Blom AM. Bikunin-not just a plasma proteinase inhibitor. Int J Biochem Cell Biol. 2000; 32(2):125-137.
41. Garantziotis S, Hollingsworth JW, Ghanayem RB, et al. Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury. J Immunol. 2007;179(6):4187-4192.
42. Wu R, Cui X, Lim YP, et al. Delayed administration of human inter-alpha inhibitor proteins reduces mortality in sepsis. Crit Care Med. 2004;32(8):1747-1752.
43. Singh K, Zhang LX, Bendelja K, et al. Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice. Pediatr Res. 2010; 68(3):242-247.
44. Yang S, Lim YP, Zhou M, et al. Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis. Crit Care Med. 2002;30(3): 617-622.
45. Chaaban H, Singh K, Huang J, Siryaporn E, Lim YP, Padbury JF. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr. 2009;154(4):620-622.
46. Lauer ME, Glant TT, Mikecz K, et al. Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factorstimulated gene-6. J Biol Chem. 2013;288(1): 205-214.
47. Hadem J, Hafer C, Schneider AS, et al. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol. 2014;14:24.
48. Johansson PI, Oliveri RS, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock. 2012;5(2):120-125.
49. Pal PK, Starr T, Gertler MM. Neutralization of heparin by histone and its subfractions. Thromb Res. 1983;31(1):69-79.
50. Capon C, Mizon C, Lemoine J, Rodié-Talbère P, Mizon J. In acute inflammation, the chondroitin-4 sulphate carried by bikunin is not only longer, it is also undersulphated. Biochimie. 2003;85(1-2): 101-107.
51. Lord MS, Day AJ, Youssef P, et al. Sulfation of the bikunin chondroitin sulfate chain determines heavy chain-hyaluronan complex formation. J Biol Chem. 2013;288(32):22930-22941.
52. Mehta D, Ravindran K, Kuebler WM. Novel regulators of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2014;307(12): L924-L935.
53. Henrich M, Gruss M, Weigand MA. Sepsisinduced degradation of endothelial glycocalix. ScientificWorldJournal. 2010;10:917-923.
54. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623-627.
55. Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8): 1217-1223.
56. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4(7): 528-539.
57. Horton MR, McKee CM, Bao C, et al. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferoninducible protein-10 in mouse macrophages. J Biol Chem. 1998;273(52):35088-35094.
58. Siegelman MH, DeGrendele HC, Estess P. Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol. 1999;66(2):315-321.
59. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002; 195(1):99-111.
60. Nakamura K, Yokohama S, Yoneda M, et al. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol. 2004;39(4):346-354.
61. Liu YY, Lee CH, Dedaj R, et al. High-molecularweight hyaluronan-a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care. 2008; 12(4):R102.
62. Sharony R, Yu PJ, Park J, Galloway AC, Mignatti P, Pintucci G. Protein targets of inflammatory serine proteases and cardiovascular disease. J Inflamm (Lond). 2010;7:45.
63. Waxler B, Rabito SF. Aprotinin: a serine protease inhibitor with therapeutic actions: its interaction with ACE inhibitors. Curr Pharm Des. 2003;9(9): 777-787.